Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratinocyte cell surface adhesion proteins are a diverse group of transmembrane molecules, including desmogleins (DSG1, DSG3), desmocollins, E-cadherin, and integrins (e.g., alpha6beta4), that are essential for maintaining the structural integrity and barrier function of the skin. These proteins organize into specialized junctions such as desmosomes, adherens junctions, and hemidesmosomes to facilitate robust cell-cell and cell-matrix attachment. In autoimmune blistering diseases like pemphigus vulgaris and pemphigus foliaceus, these proteins are the primary antigens targeted by pathogenic autoantibodies, leading to the loss of intercellular adhesion known as acantholysis. Beyond their structural roles, they also function as signaling hubs that regulate keratinocyte proliferation, differentiation, and migration, making them relevant in wound healing and cancer. In oncology, the dysregulation of these proteins, particularly the loss of E-cadherin, is a hallmark of epithelial-to-mesenchymal transition (EMT) and metastasis. Therapeutic interventions primarily focus on managing autoimmune responses through B-cell depletion or FcRn inhibition, while experimental strategies include the use of mimetic peptides to stabilize adhesion and chimeric autoantibody receptor (CAAR) T cells to selectively deplete pathogenic B cells.
Reduction of pathogenic autoantibody titers through B-cell depletion or FcRn inhibition; stabilization of protein-protein trans-interactions using mimetic peptides; selective depletion of autoantibody-producing B-cell clones; suppression of the systemic immune response.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratinocyte cell surface adhesion proteins.